Nanowear’s healthcare-at-home digital diagnostics platform is the world’s first and only FDA-approved cloth nanotechnology and closed-source AI-diagnostic platform that replaces routine in-person cardiometabolic assessments by continuously, simultaneously, and time synchronously assessing the heart, lungs, central vascular, hemodynamic and metabolic systems. Nanowear white-labels enterprise platform access, dynamic reporting, customized data services and algorithmic solutions to CROs, medtech, biotech, pharma and DTC platforms

Whitepapers
The Role of Artificial Intelligence in Healthcare (Dec 2024)
(Published by Advamed DHT Authors — Nanowear (primary), Amazon, MSFT, Medtronic, Stryker, Siemens, Apple, Abbott, Philips and J&J)

Peer Review Publications
JCTR, Nature Scientific Reports, JACC, JAMA, Nature - Cardiology Reports, Heart Rhythm Society - Cardiovascular Digital, Journal of Cardiac Failure, Cardiac Failure Review, Aesthetic Surgery Journal, Sensors MDPI, Electrochemical Society